Circassia takes on full US rights to AZ’ Tudorza
Circassia Pharmaceuticals is exercising an option to acquire the full US commercial rights to AstraZeneca’s Tudorza.
Read More
Author: Selina McKee
New NICE standards to improve digital health tech uptake
The National Institute for Health and Care Excellence has published new standards setting out the requirements needed to develop digital health technologies for the NHS, to accelerate uptake of products like healthcare apps and wearable devices.
Read More
Launch of largest ever UK lung cancer screening study
The largest ever lung cancer screening project undertaken in the UK has launched in London, aiming to detect lung cancer early among at-risk citizens.
Read More
Oxford BioTherapeutics, WuXi Biologics team up to create cancer antibodies
Oxford BioTherapeutics has entered a strategic partnership with WuXi Biologics to develop bispecific antibodies for the treatment of several cancer types, expanding on the existing collaboration between the two.
Read More
PredictSURE IBD gains CE mark, set for UK and EU launch
PredictImmune is gearing up to launch its novel prognostic test for inflammatory disease after it was awarded a CE mark.
Read More- Transgene completes randomisation in phase 2 trial of tg4050
- Bayer wins MHRA approval for Kerendia in heart failure
- Oxford BioTherapeutics signs collaboration with Bristol Myers Squibb
- Kainova expands DT 7012 trial into Europe
- Amgen reports positive phase 3 results for subcutaneous TEPEZZA in thyroid eye disease
